Exane Derivatives’s Anadarko Petroleum APC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-9
Closed -$635 715
2019
Q2
$635 Buy
+9
New +$603 ﹤0.01% 585
2019
Q1
Sell
-2,010
Closed -$88.1K 725
2018
Q4
$88.1K Buy
2,010
+1,963
+4,177% +$111K 0.02% 328
2018
Q3
$3.17K Sell
47
-3,351
-99% -$226K ﹤0.01% 474
2018
Q2
$249K Sell
3,398
-12,978
-79% -$880K 0.04% 241
2018
Q1
$964K Sell
16,376
-1,269
-7% -$74.4K 0.19% 123
2017
Q4
$946K Buy
17,645
+4,621
+35% +$227K 0.16% 105
2017
Q3
$636K Sell
13,024
-1,077
-8% -$47.5K 0.12% 121
2017
Q2
$639K Buy
14,101
+8,158
+137% +$433K 0.14% 125
2017
Q1
$368K Buy
5,943
+1,023
+21% +$68.1K 0.08% 151
2016
Q4
$343K Sell
4,920
-13,051
-73% -$849K 0.07% 182
2016
Q3
$1.14M Sell
17,971
-2,084
-10% -$116K 0.17% 90
2016
Q2
$1.07M Buy
20,055
+305
+2% +$15.5K 0.18% 83
2016
Q1
$920K Buy
+19,750
New +$801K 0.12% 95
2015
Q4
Sell
-3,413
Closed -$206K 578
2015
Q3
$206K Sell
3,413
-4,044
-54% -$287K 0.03% 184
2015
Q2
$582K Sell
7,457
-12,723
-63% -$1.1M 0.06% 132
2015
Q1
$1.67M Buy
20,180
+864
+4% +$70.7K 0.18% 71
2014
Q4
$1.59M Buy
+19,316
New +$1.68M 0.22% 79

Other funds holding APC

Exane Derivatives's APC Position: Q3 2019 in Review

Exane Derivatives sold out of Anadarko Petroleum (APC) in Q3 2019, closing a stake of 9 shares — an estimated $635 sold.

Exane Derivatives first reported a position in APC in Q4 2014 and held it in 17 quarters. The position peaked at $1.67M in Q1 2015. 8 funds tracked by Wall St. Rank hold APC as of Q3 2019.

  • Exane Derivatives reported no remaining Anadarko Petroleum position as of Q3 2019 after selling out during the quarter.
  • Exane Derivatives sold 9 Anadarko Petroleum shares in Q3 2019, an estimated $635.
  • Exane Derivatives first reported a position in Anadarko Petroleum in Q4 2014 and held it in 17 quarters.
  • Exane Derivatives's Anadarko Petroleum position peaked at $1.67M in Q1 2015.
  • 8 funds tracked by Wall St. Rank held Anadarko Petroleum as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.